Redondo, A.;
Colombo, N.;
Dreosti, L.M.;
McCormack, M.;
Rodrigues, A Nogueira;
Scambia, G.;
Roszak, A.;
Donica, M.;
Ulker, B.;
Martín, A González
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab (BEV), carboplatin (C) and paclitaxel (P) for advanced cervical cancer (aCC)
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab (BEV), carboplatin (C) and paclitaxel (P) for advanced cervical cancer (aCC)
Contributor:
Redondo, A.;
Colombo, N.;
Dreosti, L.M.;
McCormack, M.;
Rodrigues, A Nogueira;
Scambia, G.;
Roszak, A.;
Donica, M.;
Ulker, B.;
Martín, A González